GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (WBO:MRNA) » Definitions » EV-to-EBITDA

Moderna (WBO:MRNA) EV-to-EBITDA : -10.64 (As of May. 02, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Moderna EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Moderna's enterprise value is €32,536 Mil. Moderna's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €-3,058 Mil. Therefore, Moderna's EV-to-EBITDA for today is -10.64.

The historical rank and industry rank for Moderna's EV-to-EBITDA or its related term are showing as below:

WBO:MRNA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -99.24   Med: -8.04   Max: 131.53
Current: -10.62

During the past 8 years, the highest EV-to-EBITDA of Moderna was 131.53. The lowest was -99.24. And the median was -8.04.

WBO:MRNA's EV-to-EBITDA is ranked worse than
100% of 468 companies
in the Biotechnology industry
Industry Median: 9.155 vs WBO:MRNA: -10.62

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-02), Moderna's stock price is €104.60. Moderna's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-11.590. Therefore, Moderna's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Moderna EV-to-EBITDA Historical Data

The historical data trend for Moderna's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna EV-to-EBITDA Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial -10.90 -50.94 6.84 6.07 -9.33

Moderna Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.07 9.44 31.94 -18.30 -9.33

Competitive Comparison of Moderna's EV-to-EBITDA

For the Biotechnology subindustry, Moderna's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moderna's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moderna's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Moderna's EV-to-EBITDA falls into.



Moderna EV-to-EBITDA Calculation

Moderna's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=32535.686/-3058.061
=-10.64

Moderna's current Enterprise Value is €32,536 Mil.
Moderna's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3,058 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moderna  (WBO:MRNA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Moderna's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=104.60/-11.590
=At Loss

Moderna's share price for today is €104.60.
Moderna's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-11.590.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Moderna EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Moderna's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Moderna (WBO:MRNA) Business Description

Address
200 Technology Square, Cambridge, MA, USA, 02139
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna (WBO:MRNA) Headlines

From GuruFocus

Moderna Inc at UBS Global Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Moderna Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Moderna Inc Science & Technology Day Transcript

By GuruFocus Research 01-23-2024

Moderna Inc at UBS BioPharma Conference Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Moderna Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Moderna Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024